Angioimmunoblastic T-cell lymphoma: The effect of initial treatment and microvascular density in 31 patients

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2311-2316

  Zhao, Shu ^a   Zhang, Liangyu ^a,b   Zhang, Minghui ^a   Yao, Guodong ^a   Zhang, Xiaosan ^a   Zhao, Wenhui ^a   Ren, Wei ^c   Wang, Jingxuan ^a   Zhang, Qingyuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b DAQING OILFIELD CO LTD   (China)

^c First Hospital of Harbin   (China)

Author keywords

Angioimmunoblastic T cell; Chemotherapy; Microvessel density; Prognosis

Indexed keywords

ANTHRACYCLINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ABDOMINAL PAIN; ADULT; AGED; ALEUCOCYTOSIS; ALOPECIA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPERSPASMIA; HYPERURICEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; LIMB ANESTHESIA; LIMB DEFECT; MALE; MICROVESSEL DENSITY; MUSCLE SPASM; OLIGURIA; OVERALL SURVIVAL; PARALYTIC ILEUS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SIDE EFFECT; ST SEGMENT; T CELL LYMPHOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; TUMOR VASCULARIZATION; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, T-CELL; MALE; MICROVESSELS; MIDDLE AGED; PREDNISOLONE; PREDNISONE; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 84867994320     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0094-7     Document Type: Article

References (33)

1. Armitage J, Vose J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
2. Mourad N, Mounier N, Brière J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111:4463-70.
3. Gratzinger D, Zhao S, Tibshirani RJ, et al. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest. 2008;88:38-47.
4. Jaffe ES, Ralfkiaer E (2001) Angioimmunobalstic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al. (eds) World health organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 225-226.
5. Gratzinger D, Zhao S, Marinelli RJ, et al. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol1. 2007;70:1362-9.
6. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89:3909-18.
7. Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC, p 439.
8. Krenacs L, Schaerli P, Kis G, et al. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood. 2006;108:1110-1.
9. de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH). Blood. 2007;109:4952-63.
10. Vinuesa CG, Tangye SG, Moser B, et al. Follicular B helper T cells in antibody response and autoimmunity. Nat Rev Immunol. 2005;5:853-65.
11. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-33.
12. Dogan A, Attygalle AD, Kyriakou C. Angioimunoblastic T-cell lymphoma. Br J Haematol. 2003;121:681-91.
13. Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in Angioimmunoblastic T cell-lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006;30:490-4.
14. Grogg KL, Attygalle AD, Macon WR, et al. Angioimmunoblastic T cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood. 2005;106:1501-2.
15. Kim CH, Lim HW, Kim JR, et al. Unique gene expression program of human germinal center T helper cells. Blood. 2004;104:1952-60.
16. Yuan CM, Vergilio JA, Zhao XF, et al. CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CDl0+ T -cells by flow cytometry. Hum Pathol. 2005;36:784-91.
17. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68-78.
18. Ansel KM, Ngo VN, Hyman PL, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309-14.
19. Tang XF, Li GD, Li YL, et al. Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. Zhonghua Bing Li Xue Za Zhi. 2009;38:224-30.
20. Grogg KL, Attygalle AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol. 2006;19:1101-7.
21. Pautier P, Devidas A, Delmer A, et al. Angioimmunoblastic-like T-cell non Hodgkin lymphoma:outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma. 1999;32:545-52.
22. Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004;15:1215-21.
23. Vose J, Armitage J, Weisenburger D. International T-cell Lymphoma Project. International Peripheral T-cell and Natural Killer/T-Cell Lymphoma Study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
24. Lin HN, Liu CY, Hong YC, et al. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience. Leuk Lymphoma. 2010;51:2208-14.
25. Gallamini A, Zaja F, Patti C, et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007;110:2316-23.
26. Joly B, Frenkel V, Gaulard P. Rituxinmab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma(AITL). Preliminary results in 9 patients treated in a single institution. Blood. 2005;106:2686.
27. Bruns I, Fox F, Reinecke P, et al. Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab. Leukemia. 2005;19:1993-5.
28. Mori M, Inoue D, Arima H, et al. Therapeutic efficacy of cyclosporin A for refractory angioimmunoblastic T cell lymphoma. Rinsho Ketsueki. 2010;51:332-8.
29. Piekarz RL, Frye R, Prince HM, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood. 2011;117:5827-34.
30. Jorgensen JM, Sorensen FB, Bendix K, et al. Expression pattern and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR and Flt-4 in Peripheral T-cell lymhoma. Leuk Lymphoma. 2009;50:1647-60.
31. Ruan J, Hajjar K, Rafii S, Leonard JP. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma. Annal Oncol. 2009;20:413-24.
32. Kumar S, Gertz MA, Dispenzieri A, et al. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant. 2004;34:235-9.
33. Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026-36.